He would be more interesting if he was a zombie.
Kids who have recovered from COVID-19 may have an increased risk of developing diabetes, according to a new study from the Centers for Disease Control and Prevention.
The study, which looked at databases with information for over 2.5 million patients under 18, found that children diagnosed with COVID-19 were about 2.5 times more likely to receive a new diabetes diagnosis a month or more after infection.
Advertisement
The health care data, taken from the first full year of the coronavirus pandemic, showed that other, non-COVID-related infections were not found to be associated with increased risk of diabetes diagnosis, leading researchers to look for reasons for this possible link between COVID and diabetes diagnoses.
A possible link between COVID-19 and an increased risk of diabetes has also been found in adults. In June, two studies were released that showed the virus’s ability to infect pancreatic beta cells, decrease insulin secretion and effectively yield Type 1 diabetes.
https://goodmorningamerica.com/wellness/story/study-finds-covid-19-increase-risk-diabetes-kids-82212416
COPENHAGEN (Reuters) -Novo Nordisk on Wednesday rejected allegations by a U.S. congressional investigative committee that it has engaged in manoeuvres to increase net prices on life-saving insulin in tandem with competitors on the U.S. market.
The report by the House Oversight Committee, the main investigative body of the U.S. House of Representatives, alleged that Novo had raised its insulin drug prices to the detriment of diabetes patients between 2001 and 2019.
Referring to Novo, Eli Lilly and Sanofi, which account for some 90% of the U.S. insulin market, the report released in December cited internal documents saying the three drugmakers had "intentionally and strategically raised their prices in lockstep."
https://news.yahoo.com/novo-nordisk-rejects-u-report-124424640.html